Medrobotics Closes $26 Million Series E Financing

Company Prepares for European Commercialization of the Ground-Breaking Flex® System in Otolaryngology

RAYNHAM, Mass.--Medrobotics Corp., a surgical products company with core competencies in medical robotics, announced today that it had closed its $26 Million Series E Preferred Stock financing. Existing Medrobotics shareholders and undisclosed new investors participated in the Series E raise. Proceeds will be used for regulatory preparations and submissions and for anticipated commercial launches in Europe and the United States.


The Company recently announced that it had received the CE mark for its Flex® System. "The Flex® System is the first robot-assisted flexible endoscopic platform for use during surgical procedures," said Samuel Straface, Ph.D., President and CEO of Medrobotics. "It extends the capability of surgeons to look and reach around corners and operate in hard-to-reach and confined spaces."

The Flex® System enables minimally invasive surgical procedures where conventional line-of-sight technologies are either not feasible or sub-optimal. Surgeons can navigate the Flex® Scope around anatomical structures to hard-to-reach locations through a single access site, and then use the onboard high-definition vision system to precisely deploy a range of proprietary and third party flexible surgical instruments. The uniquely "wristed" 3mm Flex® Instruments, which have also received the CE mark, enable the surgeon to further extend his or her reach to important and often challenging areas of the anatomy.

Minimally invasive surgery has demonstrated advantages for patients and providers compared to traditional open procedures, decreasing hospital stays and recovery times. The Flex® System was designed to provide a cost-effective, easy-to-use, and efficient robot-assisted surgical platform for hospitals and surgeons seeking to provide minimally-invasive treatment options to more patients.

About Medrobotics

Medrobotics Corporation (www.Medrobotics.com) is a privately-held company headquartered in Raynham, Massachusetts that is developing and commercializing the Flex® System, a robotic-assist platform that provides surgeons with single-site access and visualization of hard-to-reach anatomical locations. The Company's vision is to provide more patients with access to minimally invasive surgery, and, having received the CE mark for its Flex® System, Medrobotics is preparing the commercial launch of its products in Europe. These products are not currently approved for sale in the U.S.

Featured Product

The ERT150 - Dorner’s Next Evolution of Edge Roller Technology Conveyors

The ERT150 - Dorner's Next Evolution of Edge Roller Technology Conveyors

The next evolution in Dorner's Edge Roller Technology conveyor platform, the ERT®150, is ideal for small and light-load assembly automation, as well as medical and medical-device assembly application. The ERT platform is the only pallet conveyor of its kind available with an ISO Standard Class 4 rating for cleanroom applications. Earning the ISO Standard 14644-1 Class 4 rating means Dorner's ERT150 will conform and not contribute to the contamination of cleanrooms to those standards. As implied by its name, the ERT150 (Edge Roller Technology) uses rollers to move pallets through the conveyor smoothly with no friction (a byproduct often seen in belt-driven platforms). The conveyor's open design eliminates concerns of small parts or screws dropping into rollers and causing conveyor damage or jamming. The ERT150 is suited to operate in cleanroom environments requiring a pallet handling conveyor. It is capable of zoning for no or low-back pressure accumulation and is ideal for automation assembly applications within industries including medical devices, electronics, consumer goods among others.